The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
Author: Leon Caly,Julian D. Druce,Mike G. Catton,David A. Jans,Kylie M. Wagstaff
Publication: Antiviral Research
Date: Available online 3 April 2020
You must be logged in to reply to this topic.
For comments and inquiries about the COVID-19 Pharmacology Resource Center, please fill out the Contact Us form, and we will be in touch shortly.